Today marks a significant milestone in cancer care with the introduction of bipartisan federal legislation that would revolutionize Medicare reimbursement for radiation therapy. The Radiation Oncology Case Rate (ROCR) Value-Based Payment Program Act of 2024, sponsored by Sen. Thom Tillis (R-N.C.) and by Reps. Brian Fitzpatrick (R-Pa.), Jimmy Panetta (D-Calif.) and Paul Tonko (D-N.Y.), would safeguard access to high quality cancer treatments for patients nationwide, improve patient outcomes and reduce health disparities while generating savings for Medicare. The Radiation Oncology Case Rate (ROCR) program shifts Medicare’s current per-treatment payment system to a more patient-centered approach. 

Read More